Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
318
datasets available to search
ShareScore release 0.9.0
Dataset results
318 results for “MDD”
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
ClinicalTrials.gov study NCT07111390. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ClinicalTrials.gov study NCT06786624. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)
ClinicalTrials.gov study NCT02433093. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)
ClinicalTrials.gov study NCT04455646. IPD Sharing: NO. Countries: 1. Publications: 0.
Waitlist-Control Trial of Smartphone CBT for Major Depressive Disorder (MDD)
ClinicalTrials.gov study NCT04594616. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)
ClinicalTrials.gov study NCT01185977. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)
ClinicalTrials.gov study NCT04846829. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neurobiology of Treatment Responses in MDD
ClinicalTrials.gov study NCT03068247. IPD Sharing: NO. Countries: 1. Publications: 0.
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD
ClinicalTrials.gov study NCT05381974. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ClinicalTrials.gov study NCT06911112. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)
ClinicalTrials.gov study NCT03014544. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NQ TMS for MDD Therapy Using 1 Day x 3 Sessions Protocol for Adult Patient
ClinicalTrials.gov study NCT06772987. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Waitlist-Control Trial of Smartphone CBT for Major Depressive Disorder (MDD), Withdrawn
ClinicalTrials.gov study NCT03769350. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Intermittent Doses of CERC-301 in MDD
ClinicalTrials.gov study NCT02459236. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RCT Study on the Therapeutic Effect of Escitalopram Loaded With XingpiJieyu Formula on Resting State EEG Energy Abnormalities in Severe Liver Depression and Spleen Deficiency Type MDD
ClinicalTrials.gov study NCT06758167. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)
ClinicalTrials.gov study NCT01156415. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Gaze Contingent Feedback in Major Depressive Disorder (MDD)
ClinicalTrials.gov study NCT02945735. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)
ClinicalTrials.gov study NCT01110902. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)
ClinicalTrials.gov study NCT05518149. IPD Sharing: YES. Countries: 21. Publications: 0.
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ClinicalTrials.gov study NCT06963021. IPD Sharing: NO. Countries: 4. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.